Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Disruption of Trim9 function abrogates macrophage motility in vivo.

Tokarz DA, Heffelfinger AK, Jima DD, Gerlach J, Shah RN, Rodriguez-Nunez I, Kortum AN, Fletcher AA, Nordone SK, Law JM, Heber S, Yoder JA.

J Leukoc Biol. 2017 Dec;102(6):1371-1380. doi: 10.1189/jlb.1A0816-371R. Epub 2017 Oct 11.

PMID:
29021367
2.

A hyperactive Mpl-based cell growth switch drives macrophage-associated erythropoiesis through an erythroid-megakaryocytic precursor.

Belay E, Miller CP, Kortum AN, Torok-Storb B, Blau CA, Emery DW.

Blood. 2015 Feb 5;125(6):1025-33. doi: 10.1182/blood-2014-02-555318. Epub 2014 Oct 24.

3.

JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Miller CP, Thorpe JD, Kortum AN, Coy CM, Cheng WY, Ou Yang TH, Anastassiou D, Beatty JD, Urban ND, Blau CA.

Cancer Immunol Res. 2014 Apr;2(4):301-6. doi: 10.1158/2326-6066.CIR-13-0189. Epub 2014 Jan 15.

4.

Differential expression and ligand binding indicate alternative functions for zebrafish polymeric immunoglobulin receptor (pIgR) and a family of pIgR-like (PIGRL) proteins.

Kortum AN, Rodriguez-Nunez I, Yang J, Shim J, Runft D, O'Driscoll ML, Haire RN, Cannon JP, Turner PM, Litman RT, Kim CH, Neely MN, Litman GW, Yoder JA.

Immunogenetics. 2014 Apr;66(4):267-79. doi: 10.1007/s00251-014-0759-4. Epub 2014 Jan 28.

Supplemental Content

Loading ...
Support Center